Gene therapy using hematopoietic stem cells

Curr Opin Mol Ther. 1999 Aug;1(4):437-42.

Abstract

While gene therapy using hematopoietic stem cells was the first area of investigation in the field, success has proven elusive. However, significant progress has been achieved recently in methods for more effective gene transfer and expression. In addition to greatly improved results using retroviral vectors, adeno-associated vectors and lentiviral vectors appear to be promising for stable transduction of hematopoietic stem cells. These advances, documented in animal transplant models, are now being applied to clinical trials.

Publication types

  • Review

MeSH terms

  • Adenoviridae / genetics
  • Adenoviridae / immunology
  • Animals
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology
  • Bone Marrow Diseases / chemically induced
  • Bone Marrow Diseases / genetics
  • Bone Marrow Diseases / therapy
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Dogs
  • Drug Resistance, Neoplasm / genetics
  • Gene Expression Regulation, Viral
  • Genetic Diseases, Inborn / genetics
  • Genetic Diseases, Inborn / therapy
  • Genetic Therapy / methods*
  • Genetic Vectors / genetics
  • Genetic Vectors / immunology
  • HIV Infections / therapy
  • HIV-1
  • Hematopoietic Stem Cell Transplantation*
  • Hemoglobinopathies / genetics
  • Hemoglobinopathies / therapy
  • Humans
  • Infant
  • Lentivirus / genetics
  • Lentivirus / immunology
  • Mice
  • Mice, Inbred NOD
  • Mice, Knockout
  • Mice, SCID
  • Primates
  • Radiation Chimera
  • Recombinant Fusion Proteins / immunology
  • Recombinant Fusion Proteins / physiology
  • Retroviridae / genetics
  • Retroviridae / immunology
  • Severe Combined Immunodeficiency / genetics
  • Severe Combined Immunodeficiency / therapy
  • Transplantation, Heterologous
  • Transplantation, Homologous

Substances

  • Antineoplastic Agents
  • Recombinant Fusion Proteins